Wall Street Analysts Believe CareDx (CDNA) Could Rally 28.02%: Here's is How to TradeZacks Investment Research • 11/27/25
SHORE Study Demonstrates HeartCare's Prognostic Value for Heart Transplant Recipients, Published in Journal of Heart and Lung TransplantationBusiness Wire • 11/24/25
CareDx Announces New Precision Kidney Transplant Data and Product Innovations at ASN Kidney Week 2025Business Wire • 11/06/25
CareDx (CDNA) Q3 Earnings: Taking a Look at Key Metrics Versus EstimatesZacks Investment Research • 11/05/25
CareDx Announces Appointment of Jeffrey John Teuteberg, MD as Chief Medical OfficerBusiness Wire • 10/27/25
CareDx Announces Largest Landmark Study of Its Kind on Antibody Mediated Rejection in Heart Transplantation Published in Journal of the American College of Cardiology: Heart FailureBusiness Wire • 10/23/25
CareDx Announces New IVD Products and IVDR Certification for AlloSeq® Tx and QTYPE® at the 2025 American Society of Histocompatibility & Immunogenetics Annual MeetingBusiness Wire • 10/06/25
CareDx Announces Landmark KOAR Study Published in the American Journal of TransplantationBusiness Wire • 08/06/25
CareDx Announces Landmark Data in AI-Powered Transplant Diagnostics Showcased in Over 40 Abstracts and 16 Oral Presentations at the 2025 World Transplant CongressBusiness Wire • 07/31/25
CareDx (CDNA) Surges 7.0%: Is This an Indication of Further Gains?Zacks Investment Research • 07/22/25